Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality-of-Life Assessment Following Single-Fraction Stereotactic Radiotherapy (SF-SBRT) for Inoperable Primary and Oligometastatic Lung Tumor

NCT07441941 is registered in ClinicalTrials.gov with Institut du Cancer de Montpellier - Val d'Aurelle as lead sponsor.

NCT NCT07441941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07441941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality-of-Life Assessment Following Single-Fraction Stereotactic Radiotherapy (SF-SBRT) for Inoperable Primary and Oligometastatic Lung Tumor
Lead sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Phase
Observational
Overall status
Recruiting
Start date
January 14, 2026
Completion date
November 30, 2028
Enrollment
190 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc (non-small cell lung cancer), oligometastatic lung tumor, sbrt